4//SEC Filing
Clark David J 4
Accession 0001209191-22-056635
CIK 0001563880other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:43 PM ET
Size
5.5 KB
Accession
0001209191-22-056635
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-11-14+300,000→ 300,000 totalExercise: $2.02Exp: 2032-11-13→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option was granted on November 14, 2022. The 300,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on November 14, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter, through November 14, 2026.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001662693
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:43 PM ET
- Size
- 5.5 KB